Brainstorm Cell Therapeutics Inc (STU:GHD)
€ 2.979 0 (0%) Market Cap: 9.73 Mil Enterprise Value: 7.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 36/100

Q2 2020 Brainstorm Cell Therapeutics Inc Earnings and Corporate Update Call Transcript

Aug 05, 2020 / 12:00PM GMT
Release Date Price: €160.5 (-7.76%)
Operator

Greetings, everyone, and welcome to the Brainstorm Cell Therapeutics financial results for the second quarter of 2020 and corporate updates conference call. (Operator Instructions) As a reminder, today's conference call is being recorded.

It is now my pleasure to introduce your host, Michael Woodof LifeSci Advisors. Sir, you may begin.

Michael Wood
LifeSci Advisors LLC - IR

Thank you, operator, and thank you all for joining the Brainstorm Cell Therapeutics call today. And before we begin the opening remarks, I'd like to remind listeners that this conference call contains numerous statements, descriptions, forecasts, and projections regarding Brainstorm Cell Therapeutics, and its future business operations and performance, statements regarding the market potential for the treatment of neurodegenerative disorders such as ALS and MS, the sufficiency of the company's existing capital resources for continuing operations in 2020 and beyond, the safety and clinical effectiveness of newer technology platforms, clinical trials of NurOwn, and related clinical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot